CA1030522A - D-homo-20-keto-pregnanes - Google Patents

D-homo-20-keto-pregnanes

Info

Publication number
CA1030522A
CA1030522A CA215,097A CA215097A CA1030522A CA 1030522 A CA1030522 A CA 1030522A CA 215097 A CA215097 A CA 215097A CA 1030522 A CA1030522 A CA 1030522A
Authority
CA
Canada
Prior art keywords
pregnanes
keto
homo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA215,097A
Other languages
English (en)
French (fr)
Other versions
CA215097S (en
Inventor
Klaus Kieslich
Karl Petzoldt
Rudolf Wiechert
Reinhard Horowski
Gert Paschelke
Dieter Palenschat
Ulrich Kerb
Helmut Wachtel
Wolfgang Kehr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2360443A external-priority patent/DE2360443A1/de
Priority claimed from DE19742445161 external-priority patent/DE2445161A1/de
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of CA1030522A publication Critical patent/CA1030522A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
CA215,097A 1973-11-30 1974-12-02 D-homo-20-keto-pregnanes Expired CA1030522A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2360443A DE2360443A1 (de) 1973-11-30 1973-11-30 D-homo-20-ketopregnane
DE19742445161 DE2445161A1 (de) 1974-09-19 1974-09-19 D-homo-20-ketopregnane ii

Publications (1)

Publication Number Publication Date
CA1030522A true CA1030522A (en) 1978-05-02

Family

ID=25766200

Family Applications (1)

Application Number Title Priority Date Filing Date
CA215,097A Expired CA1030522A (en) 1973-11-30 1974-12-02 D-homo-20-keto-pregnanes

Country Status (14)

Country Link
US (1) US4045574A (enEXAMPLES)
JP (1) JPS5084561A (enEXAMPLES)
AT (1) AT347611B (enEXAMPLES)
CA (1) CA1030522A (enEXAMPLES)
CH (1) CH618183A5 (enEXAMPLES)
DD (1) DD115659A5 (enEXAMPLES)
DK (1) DK134348C (enEXAMPLES)
ES (1) ES432106A1 (enEXAMPLES)
FR (1) FR2253512B1 (enEXAMPLES)
GB (1) GB1494097A (enEXAMPLES)
IE (1) IE40423B1 (enEXAMPLES)
IL (1) IL46153A (enEXAMPLES)
NL (1) NL7415577A (enEXAMPLES)
SE (1) SE408426B (enEXAMPLES)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879316A (en) * 1987-02-26 1989-11-07 The University Of Tennessee Research Corporation Interpenetrating polymer network ion exchange membranes and method for preparing same
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
CA2495412A1 (en) * 2002-08-16 2004-02-26 Pharmacia & Upjohn Company 5 androsten-3.beta.-ol steroid intermediates and processes for their preparation
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
RU2700264C2 (ru) 2013-04-17 2019-09-16 Сейдж Терапьютикс, Инк. 19-нор нейроактивные стероиды и способы их применения
EP2986623B1 (en) 2013-04-17 2018-11-07 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
PT3021852T (pt) 2013-07-19 2021-04-21 Sage Therapeutics Inc Esteroides neuroativos, composições e utilizações das mesmas
ES2848823T3 (es) 2013-08-23 2021-08-12 Sage Therapeutics Inc Esteroides neuroactivos, composiciones y usos de los mismos
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
SMT202000414T1 (it) 2014-10-16 2020-09-10 Sage Therapeutics Inc Composizioni e metodi per trattare disturbi del snc
AU2015331749A1 (en) 2014-10-16 2017-05-04 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
RS60343B1 (sr) 2014-11-27 2020-07-31 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns-a
JP6745274B2 (ja) 2015-01-26 2020-08-26 セージ セラピューティクス， インコーポレイテッド Ｃｎｓ障害を処置するための組成物および方法
EP3258939B1 (en) 2015-02-20 2022-09-07 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP3481844B1 (en) 2016-07-11 2024-04-17 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
EP3481845B1 (en) 2016-07-11 2023-09-13 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
US20220315621A1 (en) * 2017-12-22 2022-10-06 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
US20230322846A9 (en) 2018-12-05 2023-10-12 Sage Therapeutics, Inc. Neuroactive steroids and their methods of use
CN116059215B (zh) 2019-01-08 2025-10-03 成都康弘药业集团股份有限公司 甾体类化合物、用途及其制备方法
CA3139554A1 (en) 2019-05-31 2020-12-03 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof
AU2020304679A1 (en) * 2019-06-27 2022-01-20 Sage Therapeutics, Inc. Compounds for treating CNS disorders
US20230085354A1 (en) * 2019-06-27 2023-03-16 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860158A (en) * 1954-10-18 1958-11-11 Sterling Drug Inc Compounds of the perhydrochrysene series and preparation thereof
US3686223A (en) * 1968-12-26 1972-08-22 Sterling Drug Inc D-homoestratrienes
US3833621A (en) * 1972-03-20 1974-09-03 Richardson Merrell Inc 3-keto-7(alpha,beta)-loweralkyl-delta5 steroids and process for preparing same

Also Published As

Publication number Publication date
SE408426B (sv) 1979-06-11
DK604174A (enEXAMPLES) 1975-07-28
CH618183A5 (enEXAMPLES) 1980-07-15
FR2253512A1 (enEXAMPLES) 1975-07-04
DK134348B (da) 1976-10-25
IL46153A (en) 1979-01-31
IL46153A0 (en) 1975-02-10
AU7586774A (en) 1976-06-03
NL7415577A (nl) 1975-06-03
US4045574A (en) 1977-08-30
AT347611B (de) 1979-01-10
ATA950774A (de) 1978-05-15
SE7414960L (enEXAMPLES) 1975-06-02
JPS5084561A (enEXAMPLES) 1975-07-08
FR2253512B1 (enEXAMPLES) 1978-02-03
IE40423B1 (en) 1979-05-23
GB1494097A (en) 1977-12-07
DK134348C (da) 1977-03-21
ES432106A1 (es) 1976-11-01
IE40423L (en) 1975-05-30
DD115659A5 (enEXAMPLES) 1975-10-12

Similar Documents

Publication Publication Date Title
AU474137B2 (en) Auto-refractometer
AU468964B2 (en) Melik
CA1030522A (en) D-homo-20-keto-pregnanes
CA1034948A (en) Triazolopyridazines
AU498889B2 (en) Piperidylene benzocycloheptathiophenes
AU476397B2 (en) A-cycloalkylbenzyl lactamimides
AU476505B2 (en) Alkylbenxyl lactamimides
CA1024058A (en) Firecheck
CA1017743A (en) Benzylpyrimidines
CA1020564A (en) Phenyl-thiadiazolyl-thiourea
CA998215A (en) Warmhouse
AU476386B2 (en) Dibenzocycloheptenyl lactamimides
CA1007225A (en) Polycycloanilines
CA1031349A (en) Thiadiazolylimidazolidinones
AU471241B2 (en) Benzothiazolylureas
AU482276B2 (en) Spiro-cyclopropanes
AU491458B2 (en) 7-halomethyl-17-hydroxy-3-oxo-17 -pregn-4-ene-21-carboxylic acid -lactones
AU466103B2 (en) Cis-chrysanthemate
CA1022173A (en) 5-trifluoromethyl-7-aminobenzimidazoles
AU482530B2 (en) Benzocycloheptathiophenes
CA1018984A (en) 5-trifluoromethyl-7-nitrobenzimidazoles
AU489559B2 (en) Amidinoureas
AU482866B2 (en) Unsymmetrically-substituted-s-triazines
AU484993B2 (en) Polyhydroxyphenylchromanones
AU487916B2 (en) Benzopyranopyridines